Selection of DNA aptamers against rat liver X receptors

被引:17
|
作者
Surugiu-Wärnmark, I
Wärnmark, A
Toresson, G
Gustafsson, JA
Bülow, L
机构
[1] Lund Univ, Ctr Chem & Chem Engn, Dept Pure & Appl Biochem, SE-22100 Lund, Sweden
[2] Karolinska Inst, Novum, Dept Biosci, SE-14157 Huddinge, Sweden
关键词
SELEX; aptamer; LXR alpha; LXR beta; SPR;
D O I
10.1016/j.bbrc.2005.04.147
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Liver X receptors alpha and beta (LXR alpha; LXR beta) are members of the nuclear hormone receptor superfamily of ligand-activated transcription factors. LXRs play an important role in the reverse cholesterol transport and govern the expression of many of the proteins that are indispensable for the regulation of normal cholesterol levels in the body. SELEX, an in vitro selection technology, was used on a single stranded DNA library harboring a 12 randomized nucleotide sequence in order to isolate aptamers showing affinity for LXR alpha. Enzyme-linked assays and surface plasmon resonance measurements showed that the selected aptamers had strong affinities for LXRa with apparent dissociation constants, K(d)s, in nanomolar range. All clones carried CG-repeats, indicating a probability for a similar manner of binding to LXR alpha. Very high cross-reactivities were observed when testing the aptamers with LXR beta (up to 700%) and RXR alpha (up to 50%). If instead we regard the aptamer sequences as selected against LXR beta, the cross-reactivities decrease considerably, to 17% for LXR alpha and 7% for RXR alpha. Therefore, in the future we are planning to use the obtained aptamers as binders for LXR beta. (C) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:512 / 517
页数:6
相关论文
共 50 条
  • [1] Selection and characterization of DNA aptamers against PrPSc
    Wang, Ping
    Hatcher, Kristen L.
    Bartz, Jason C.
    Chen, Shu G.
    Skinner, Pamela
    Richt, Juergen
    Liu, Hong
    Sreevatsan, Srinand
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2011, 236 (04) : 466 - 476
  • [2] Selection and characterization of DNA aptamers against the steroid testosterone
    Vasso Skouridou
    Miriam Jauset-Rubio
    Pablo Ballester
    Abdulaziz S. Bashammakh
    Mohammad S. El-Shahawi
    Abdulrahman O. Alyoubi
    Ciara K. O’Sullivan
    Microchimica Acta, 2017, 184 : 1631 - 1639
  • [3] Selection and characterization of DNA aptamers against the steroid testosterone
    Skouridou, Vasso
    Jauset-Rubio, Miriam
    Ballester, Pablo
    Bashammakh, Abdulaziz S.
    El-Shahawi, Mohammad S.
    Alyoubi, Abdulrahman O.
    O'Sullivan, Ciara K.
    MICROCHIMICA ACTA, 2017, 184 (06) : 1631 - 1639
  • [4] In vitro selection of DNA aptamers against human osteosarcoma
    Tsogtbaatar, Khaliunsarnai
    Sousa, Diana A.
    Ferreira, Debora
    Tevlek, Atakan
    Aydin, Halil Murat
    Celik, Eda
    Rodrigues, Ligia
    INVESTIGATIONAL NEW DRUGS, 2022, 40 (01) : 172 - 181
  • [5] In vitro selection of DNA aptamers against staphylococcal enterotoxin A
    Oliveira, Ricardo
    Pinho, Eva
    Barros, Maria Margarida
    Azevedo, Nuno Filipe
    Almeida, Carina
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [6] In vitro selection of DNA aptamers against human osteosarcoma
    Khaliunsarnai Tsogtbaatar
    Diana A. Sousa
    Debora Ferreira
    Atakan Tevlek
    Halil Murat Aydın
    Eda Çelik
    Ligia Rodrigues
    Investigational New Drugs, 2022, 40 : 172 - 181
  • [7] Aptamers Against Cell Surface Receptors: Selection, Modification and Application
    Wang, J.
    Li, G.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (27) : 4107 - 4116
  • [8] Selection of DNA aptamers against DC-SIGN protein
    Yan, Hui
    Li, Shan
    Zhou, Lin-fu
    Zhu, Jian-hua
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2007, 306 (1-2) : 71 - 77
  • [9] Selection of DNA aptamers against DC-SIGN protein
    Yan Hui
    Li Shan
    Zhou Lin-fu
    Zhu Jian-hua
    Molecular and Cellular Biochemistry, 2007, 306 : 71 - 77
  • [10] Selection of Aptamers Against Chemokine Receptors and characterization of Their Potential Functions in Signaling
    Li, Chen
    Burnett, John C.
    MOLECULAR THERAPY, 2020, 28 (04) : 466 - 467